Rokos Capital Management LLP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
Rokos Capital Management LLP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$29,612,782
-27.7%
1,106,813
-16.9%
0.22%
-45.8%
Q2 2023$40,965,902
+2.2%
1,331,813
+20.3%
0.40%
-86.6%
Q1 2023$40,077,698
+107.5%
1,106,813
+124.9%
2.96%
+250.4%
Q4 2022$19,312,566
-3.0%
492,2280.0%0.85%
+42.7%
Q3 2022$19,901,000
-3.4%
492,2280.0%0.59%
-1.8%
Q2 2022$20,604,000
+50.9%
492,228
+47.5%
0.60%
+122.1%
Q2 2021$13,658,000333,7780.27%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders